PRECISION BIOSCIENCES INC Shareholders' Equity
PRECISION BIOSCIENCES INC (DTIL) had Shareholders' Equity of $45.29 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $45.29M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $76.10M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $92.25M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $16.63M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $45.29M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $76.10M 10-Q · filed 2026-08-06 |
| 2025-12-31 | $92.25M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $16.63M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $34.05M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $49.34M 10-Q · filed 2026-08-06 |
| 2024-12-31 | $56.39M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $64.87M 10-Q · filed 2025-11-03 |
| 2024-06-30 | $74.71M 10-Q · filed 2025-11-03 |
| 2024-03-31 | $37.21M 10-Q · filed 2025-11-03 |
| 2023-12-31 | $18.86M 10-K · filed 2026-03-12 |
| 2023-09-30 | $29.06M 10-Q · filed 2024-11-04 |
| 2023-06-30 | $34.04M 10-Q · filed 2024-11-04 |
| 2023-03-31 | $40.18M 10-Q · filed 2024-11-04 |
| 2022-12-31 | $60.43M 10-K · filed 2025-03-26 |
| 2022-09-30 | $84.38M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $103.02M 10-Q · filed 2023-11-07 |
| 2022-03-31 | $69.66M 10-Q · filed 2023-11-07 |
| 2021-12-31 | $91.17M 10-K · filed 2024-03-27 |
| 2021-09-30 | $101.44M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $100.55M 10-Q · filed 2022-11-08 |
| 2021-03-31 | $58.82M 10-Q · filed 2022-11-08 |
| 2020-12-31 | $44.42M 10-K · filed 2023-03-09 |
| 2020-09-30 | $63.82M 10-Q · filed 2021-11-10 |
| 2020-06-30 | $85.60M 10-Q · filed 2021-11-10 |
| 2020-03-31 | $115.03M 10-Q · filed 2021-11-10 |
| 2019-12-31 | $138.31M 10-K · filed 2022-03-15 |
| 2019-09-30 | $155.79M 10-Q · filed 2020-11-10 |
| 2019-06-30 | $173.98M 10-Q · filed 2020-11-10 |
| 2019-03-31 | $10.83M 10-Q · filed 2020-11-10 |
| 2018-12-31 | $39.96M 10-K · filed 2021-03-18 |
| 2018-09-30 | $53.59M 10-Q · filed 2019-11-12 |
| 2018-06-30 | $41.11M 10-Q · filed 2019-11-12 |
| 2018-03-31 | -$35.21M 10-Q · filed 2019-11-12 |
| 2017-12-31 | -$26.37M 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |